Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

STREPTOZOCIN: 176 Adverse Event Reports & Safety Profile

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
176
Total FAERS Reports
40 (22.7%)
Deaths Reported
56
Hospitalizations
176
As Primary/Secondary Suspect
25
Life-Threatening
4
Disabilities
May 7, 1982
FDA Approved
ESTEVE PHARMACEUTICALS, S.A.
Manufacturer
Discontinued
Status

Drug Class: Alkylating Activity [MoA] · Route: INTRAVENOUS · Manufacturer: ESTEVE PHARMACEUTICALS, S.A. · FDA Application: 050577 · HUMAN PRESCRIPTION DRUG · FDA Label: Available

First Report: 200806 · Latest Report: 20210622

What Are the Most Common STREPTOZOCIN Side Effects?

#1 Most Reported
Malignant neoplasm progression
31 reports (17.6%)
#2 Most Reported
Product use in unapproved indication
29 reports (16.5%)
#3 Most Reported
Drug ineffective
25 reports (14.2%)

All STREPTOZOCIN Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Malignant neoplasm progression 31 17.6% 3 20
Product use in unapproved indication 29 16.5% 6 13
Drug ineffective 25 14.2% 3 8
Toxicity to various agents 24 13.6% 8 0
Hypoglycaemia 23 13.1% 1 12
Nausea 23 13.1% 0 18
Nephropathy toxic 23 13.1% 0 0
Off label use 23 13.1% 10 8
Chronic kidney disease 22 12.5% 0 0
Fatigue 22 12.5% 1 12
Pancreatic neuroendocrine tumour 21 11.9% 0 16
Cardiac failure 17 9.7% 12 7
Disease progression 17 9.7% 5 2
Left ventricular dysfunction 16 9.1% 9 0
Decreased appetite 13 7.4% 0 11
Dry mouth 12 6.8% 0 3
Sepsis 12 6.8% 2 1
Thrombocytopenia 12 6.8% 5 6
Vomiting 12 6.8% 0 6
Weight decreased 12 6.8% 0 11

Who Reports STREPTOZOCIN Side Effects? Age & Gender Data

Gender: 44.9% female, 55.1% male. Average age: 59.2 years. Most reports from: FR. View detailed demographics →

Is STREPTOZOCIN Getting Safer? Reports by Year

YearReportsDeathsHosp.
2008 1 1 1
2012 3 1 1
2013 7 0 5
2015 1 0 0
2016 24 11 15
2017 1 1 1
2018 17 0 13
2020 3 0 2
2021 2 1 1

View full timeline →

What Is STREPTOZOCIN Used For?

IndicationReports
Pancreatic neuroendocrine tumour 90
Neuroendocrine tumour 18
Pancreatic neuroendocrine tumour metastatic 17
Product used for unknown indication 9
Insulinoma 8
Adrenocortical carcinoma 6
Metastases to liver 5

STREPTOZOCIN vs Alternatives: Which Is Safer?

STREPTOZOCIN vs STRIBILD STREPTOZOCIN vs SUBOXONE STREPTOZOCIN vs SUBUTEX STREPTOZOCIN vs SUCCINYLCHOLINE STREPTOZOCIN vs SUCRALFATE STREPTOZOCIN vs SUCROFERRIC OXYHYDROXIDE STREPTOZOCIN vs SUCROSE STREPTOZOCIN vs SUFENTANIL STREPTOZOCIN vs SUGAMMADEX STREPTOZOCIN vs SULBACTAM

Other Drugs in Same Class: Alkylating Activity [MoA]

BENDAMUSTINE (19,667) TEMOZOLOMIDE (17,007) IFOSFAMIDE (17,004) MELPHALAN (16,061) BUSULFAN (11,254) THIOTEPA (6,836) PROCARBAZINE (6,373) DACARBAZINE (5,105) View all → Class side effects → Compare in class →

Official FDA Label for STREPTOZOCIN

Official prescribing information from the FDA-approved drug label.